US5854037A
(en)
*
|
1989-08-28 |
1998-12-29 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand RNA virus expression systems and vaccines
|
US5166057A
(en)
*
|
1989-08-28 |
1992-11-24 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Recombinant negative strand rna virus expression-systems
|
US20060019350A1
(en)
*
|
1989-08-28 |
2006-01-26 |
Peter Palese |
Recombinant negative strand RNA virus expression system and vacccines
|
US5840520A
(en)
*
|
1989-08-28 |
1998-11-24 |
Aviron |
Recombinant negative strand RNA virus expression systems
|
US6887699B1
(en)
*
|
1990-05-22 |
2005-05-03 |
Medimmune Vaccines, Inc. |
Recombinant negative strand RNA virus expression systems and vaccines
|
KR970005274B1
(ko)
*
|
1990-08-14 |
1997-04-15 |
아이시스 파마슈티칼스, 인코포레이티드 |
안티센스 올리고뉴클레오티드에 의한 a형 인플루엔자 바이러스, 안 아아보스트레인(ann arbor strain) h2n2의 억제
|
US5837261A
(en)
*
|
1990-09-25 |
1998-11-17 |
Cantab Pharmaceuticals Research Limited |
Viral vaccines
|
US5665362A
(en)
*
|
1990-09-25 |
1997-09-09 |
Cantab Pharmaceuticals Research Limited |
Viral vaccines
|
US7374768B1
(en)
*
|
1990-09-25 |
2008-05-20 |
Xenova Research Limited |
Viral vaccines
|
EP0492920A1
(de)
*
|
1990-12-24 |
1992-07-01 |
Merck & Co. Inc. |
Chimärer Influenza-HIV Impfstoff
|
CA2084180A1
(en)
*
|
1991-12-11 |
1993-06-12 |
Paul P. Hung |
Expression of specific immunogens using viral antigens
|
WO1993021306A1
(en)
*
|
1992-04-14 |
1993-10-28 |
The Mount Sinai School Of Medicine Of The City University Of New York |
Genetically engineered attenuated viruses
|
AU5743894A
(en)
*
|
1992-12-07 |
1994-07-04 |
Mariano E Busso |
Method for detecting a virus
|
EP0711340A4
(de)
*
|
1993-06-11 |
1998-02-04 |
Peter M Palese |
Hohe ausbeuten an influenzenvirus
|
US7344722B1
(en)
*
|
1993-06-29 |
2008-03-18 |
The Regents Of The University Of Michigan |
Cold-adapted influenza virus
|
AU2359195A
(en)
*
|
1994-04-19 |
1995-11-10 |
Thomas Jefferson University |
Viral ribonucleocapsid as an immunological enhancer
|
US6150131A
(en)
*
|
1994-05-20 |
2000-11-21 |
Palese; Peter |
Method for detecting antivirals that inhibit acylation/palmitylation of hemagglutinin
|
ES2210273T5
(es)
*
|
1994-07-18 |
2010-03-29 |
Conzelmann, Karl-Klaus, Prof. Dr. |
Virus con arn de cadena negativa no segmentado recombinante infeccioso.
|
US5716821A
(en)
*
|
1994-09-30 |
1998-02-10 |
Uab Research Foundation |
Prevention and treatment of respiratory tract disease
|
WO1996010633A1
(en)
*
|
1994-09-30 |
1996-04-11 |
Aviron |
Chimeric influenza virus and electroporation method
|
WO1996010400A1
(en)
*
|
1994-09-30 |
1996-04-11 |
The Uab Research Foundation |
Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses
|
US5597697A
(en)
*
|
1994-09-30 |
1997-01-28 |
Diamond; Paul |
Screening assay for inhibitors and activators of RNA and DNA-dependent nucleic acid polymerases
|
EP0704533A1
(de)
*
|
1994-09-30 |
1996-04-03 |
Bayer Ag |
Abgeschwächtes Impfvirus, Verfahren zur dessen Herstellung und Arzneimittel die es enthalten
|
US20030054505A1
(en)
*
|
1997-09-26 |
2003-03-20 |
Hong Jin |
Recombinant rsv expression systems and vaccines
|
US7465574B2
(en)
*
|
1994-09-30 |
2008-12-16 |
Medimmune, Llc |
Recombinant RSV virus expression systems and vaccines
|
US5756341A
(en)
*
|
1994-11-10 |
1998-05-26 |
Immuno Ag |
Method for controlling the infectivity of viruses
|
US6146873A
(en)
*
|
1994-11-10 |
2000-11-14 |
Baxter Aktiengesellschaft |
Production of orthomyxoviruses in monkey kidney cells using protein-free media
|
US5753489A
(en)
*
|
1994-11-10 |
1998-05-19 |
Immuno Ag |
Method for producing viruses and vaccines in serum-free culture
|
US5698433A
(en)
*
|
1994-11-10 |
1997-12-16 |
Immuno Ag |
Method for producing influenza virus and vaccine
|
DE19503082A1
(de)
*
|
1995-02-01 |
1996-08-08 |
Univ Ludwigs Albert |
Gegenstand und Verfahren zur bevorzugt transienten Expression und möglichen Translation spezifischer RNA im cytoplasmatischen Bereich höherer eukaryontischer Zellen
|
US7153510B1
(en)
*
|
1995-05-04 |
2006-12-26 |
Yale University |
Recombinant vesiculoviruses and their uses
|
DK0780475T4
(da)
*
|
1995-08-09 |
2006-10-23 |
Schweiz Serum & Impfinst |
Fremgangsmåde til fremstilling af infektiöse negativ-streng RNA-virus
|
KR100754091B1
(ko)
|
1995-10-31 |
2007-08-31 |
가부시끼가이샤 디나벡 겡뀨쇼 |
자율 복제 능력을 갖는 (-)쇄 rna 바이러스 벡터
|
WO1997016539A1
(fr)
*
|
1995-11-01 |
1997-05-09 |
Dnavec Research Inc. |
Virus sendai recombinant
|
ES2109189B1
(es)
*
|
1996-03-14 |
1998-05-16 |
Iberica Cyanamid |
Vectores basados en genomas virales defectivos recombinantes y su empleo en la formulacion de vacunas.
|
WO1997041245A1
(en)
*
|
1996-05-01 |
1997-11-06 |
The Government Of The United States Of America, Represented By The Secretary Of The Department Of Health And Human Services |
Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins
|
US6022863A
(en)
*
|
1996-05-21 |
2000-02-08 |
Yale University |
Regulation of gene expression
|
US5939262A
(en)
*
|
1996-07-03 |
1999-08-17 |
Ambion, Inc. |
Ribonuclease resistant RNA preparation and utilization
|
US5677124A
(en)
*
|
1996-07-03 |
1997-10-14 |
Ambion, Inc. |
Ribonuclease resistant viral RNA standards
|
JP2001500738A
(ja)
|
1996-09-17 |
2001-01-23 |
カイロン コーポレイション |
細胞内疾患を処置するための組成物および方法
|
US6544523B1
(en)
|
1996-11-13 |
2003-04-08 |
Chiron Corporation |
Mutant forms of Fas ligand and uses thereof
|
US20030125280A1
(en)
*
|
1996-12-03 |
2003-07-03 |
Medical University Of South Carolina |
Tissue specific and target RNA-specific ribozymes as antimicrobial therapeutics against microbial pathogens
|
US6884414B1
(en)
*
|
1997-04-30 |
2005-04-26 |
Mount Sinai School Of Medicine Of New York University |
Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents
|
BR9809240A
(pt)
|
1997-05-07 |
2000-06-27 |
Cleveland Clinic Foundation |
Clone de hpiv recombinante, processos para preparar vìrus parainfluenza humano recombinante e para introduzir uma mutação especìfica de sìtio dentro do genoma de um vìrus parainfluenza humano, e, célula hospedeira
|
WO1999006576A1
(en)
|
1997-08-04 |
1999-02-11 |
Calydon, Inc. |
A human glandular kallikrein enhancer, vectors comprising the enhancer and methods of use thereof
|
US6872518B2
(en)
*
|
1997-09-22 |
2005-03-29 |
University Of Rochester |
Methods for selecting polynucleotides encoding T cell epitopes
|
US6830748B1
(en)
*
|
1997-09-26 |
2004-12-14 |
Medimmune Vaccines, Inc. |
Recombinant RSV virus expression systems and vaccines
|
BR9813930A
(pt)
|
1997-11-06 |
2006-12-19 |
Chiron Spa |
antìgeno neisserial
|
EP1047784B2
(de)
|
1998-01-14 |
2015-03-18 |
Novartis Vaccines and Diagnostics S.r.l. |
Antigene aus neisseria meningitidis
|
KR100440044B1
(ko)
*
|
1998-02-27 |
2004-07-14 |
팸진 비.브이. |
핵산의 비특이적 증폭방법
|
EP1066395B1
(de)
*
|
1998-03-27 |
2005-09-14 |
Cytos Biotechnology AG |
Induzierendes alphavirengen- expressionssystem
|
NZ532665A
(en)
|
1998-05-01 |
2005-11-25 |
Inst Genomic Research |
Neisseria meningitidis antigens and compositions
|
DK2316923T3
(en)
*
|
1998-06-12 |
2018-01-08 |
Icahn School Med Mount Sinai |
Attenuated influenza viruses with altered interferon antagonist activity for use as vaccines and drugs
|
DE69937999T2
(de)
|
1998-06-12 |
2009-01-29 |
Avir Green Hills Biotechnology Research Development Trade Ag |
Interferon induzierende genetisch veränderte attenuierte viren
|
AU4830899A
(en)
*
|
1998-06-24 |
2000-01-10 |
Musc Foundation For Research Development |
Tissue-specific and target rna-specific ribozymes
|
EP1100545A4
(de)
*
|
1998-07-29 |
2002-03-20 |
Invitrogen Corp |
Regulierte expression von rekombinanten proteinen unter verwendung von rns-viren
|
US6544785B1
(en)
*
|
1998-09-14 |
2003-04-08 |
Mount Sinai School Of Medicine Of New York University |
Helper-free rescue of recombinant negative strand RNA viruses
|
US6146642A
(en)
*
|
1998-09-14 |
2000-11-14 |
Mount Sinai School Of Medicine, Of The City University Of New York |
Recombinant new castle disease virus RNA expression systems and vaccines
|
US7326542B2
(en)
*
|
1998-12-02 |
2008-02-05 |
Princeton University |
Compositions and methods for regulating bacterial pathogenesis
|
US6720415B2
(en)
*
|
1998-12-02 |
2004-04-13 |
Princeton University |
Compositions and methods for regulating bacterial pathogenesis
|
EP1035209A1
(de)
*
|
1999-03-06 |
2000-09-13 |
ARTEMIS Pharmaceuticals GmbH |
Stabile rekombinante Influenzaviren, die frei von Helfervirus sind
|
US6864235B1
(en)
|
1999-04-01 |
2005-03-08 |
Eva A. Turley |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US6911429B2
(en)
*
|
1999-04-01 |
2005-06-28 |
Transition Therapeutics Inc. |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
US8715940B2
(en)
*
|
1999-04-06 |
2014-05-06 |
Wisconsin Alumni Research Foundation |
Method of making recombinant influenza virus
|
US6271359B1
(en)
|
1999-04-14 |
2001-08-07 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
WO2000061804A1
(en)
*
|
1999-04-14 |
2000-10-19 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
NZ571167A
(en)
|
1999-04-30 |
2010-05-28 |
Novartis Vaccines & Diagnostic |
Fragments from Neisseria protein ORF 953 and their use in medicaments and diagnostic reagents
|
GB9911683D0
(en)
|
1999-05-19 |
1999-07-21 |
Chiron Spa |
Antigenic peptides
|
GB9916529D0
(en)
|
1999-07-14 |
1999-09-15 |
Chiron Spa |
Antigenic peptides
|
CA2380514A1
(en)
*
|
1999-07-30 |
2001-02-08 |
George Gow Brownlee |
Attenuated influenza virus useful as vaccine
|
EP2975127A1
(de)
|
1999-10-29 |
2016-01-20 |
GlaxoSmithKline Biologicals SA |
Neisseria antigenpeptide
|
WO2001042442A2
(en)
|
1999-12-10 |
2001-06-14 |
Cytos Biotechnology Ag |
Activation of endogenous genes by genomic introduction of a replicon
|
EP2275129A3
(de)
|
2000-01-17 |
2013-11-06 |
Novartis Vaccines and Diagnostics S.r.l. |
Ergänzter Außenmembranvesikel-Impfstoff gegen Meningokokken
|
US6764685B1
(en)
|
2000-03-21 |
2004-07-20 |
Medimmune Vaccines, Inc. |
Recombinant parainfluenza virus expression systems and vaccines
|
US20030194696A1
(en)
*
|
2000-03-28 |
2003-10-16 |
University Of Rochester |
Methods of producing a library and methods of selecting polynucleotides of interest
|
US7067251B2
(en)
*
|
2000-03-28 |
2006-06-27 |
University Of Rochester |
Methods of directly selecting cells expressing inserts of interest
|
US6635416B2
(en)
*
|
2000-04-10 |
2003-10-21 |
Mount Sinai School Of Medicine Of New York University |
Screening methods for identifying viral proteins with interferon antagonizing functions and potential antiviral agents
|
EP1702983A3
(de)
|
2000-04-13 |
2007-01-10 |
Medical University of South Carolina |
Gewebespezifische und pathogenspezifische giftige Verbindungen, Ribozyme, DNAzyme und Antisenseolinukleotide sowie Anwendungen dafür
|
ATE420189T1
(de)
|
2000-04-28 |
2009-01-15 |
St Jude Childrens Res Hospital |
Dna-transfektionssystem zur erzeugung von infektiösen negativsträngigen rna virus
|
WO2001086498A2
(en)
*
|
2000-05-12 |
2001-11-15 |
Cyril John Higgins |
Method of organized retrieval of world-wide web pages
|
EP1950297A2
(de)
|
2000-05-31 |
2008-07-30 |
Novartis Vaccines and Diagnostics, Inc. |
Zusammensetzungen und Verfahren zur Behandlung neoplastischer Erkrankungen mithilfe von Chemotherapie und Strahlungssensibilisatoren
|
CN1455816A
(zh)
*
|
2000-06-23 |
2003-11-12 |
美国氰胺公司 |
从cDNA中挽救犬热病病毒
|
US20020012982A1
(en)
*
|
2000-07-13 |
2002-01-31 |
Invitrogen Corporation |
Methods and compositions for rapid protein and peptide extraction and isolation using a lysis matrix
|
US7691821B2
(en)
|
2001-09-19 |
2010-04-06 |
University Of South Florida |
Inhibition of SHIP to enhance stem cell harvest and transplantation
|
US20020165192A1
(en)
*
|
2000-09-19 |
2002-11-07 |
Kerr William G. |
Control of NK cell function and survival by modulation of ship activity
|
SG165981A1
(en)
|
2000-10-27 |
2010-11-29 |
Chiron Srl |
Nucleic acids and proteins from streptococcus groups a & b
|
CA2436519A1
(en)
*
|
2000-12-07 |
2002-06-13 |
The Penn State Research Foundation |
Selection of catalytic nucleic acids targeted to infectious agents
|
WO2002098457A2
(en)
*
|
2001-01-17 |
2002-12-12 |
Thomas Jefferson University |
Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses
|
US8715922B2
(en)
*
|
2001-01-19 |
2014-05-06 |
ViroNovative |
Virus causing respiratory tract illness in susceptible mammals
|
US20030232061A1
(en)
*
|
2001-10-18 |
2003-12-18 |
Fouchier Ronaldus Adrianus Maria |
Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
|
SG149684A1
(en)
|
2001-01-19 |
2009-02-27 |
Vironovative Bv |
A virus causing respiratory tract illness in susceptible animals
|
GB0107658D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Streptococcus pneumoniae
|
GB0107661D0
(en)
|
2001-03-27 |
2001-05-16 |
Chiron Spa |
Staphylococcus aureus
|
AU2002309133A1
(en)
|
2001-04-17 |
2002-10-28 |
Institut Pasteur |
Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
|
GB0123276D0
(en)
|
2001-09-27 |
2001-11-21 |
Imp College Innovations Ltd |
Uses of agents that bind immune-system components
|
EP2335723A1
(de)
|
2001-12-12 |
2011-06-22 |
Novartis Vaccines and Diagnostics S.r.l. |
Immunisierung gegen Chlamydia trachomatis
|
US7820435B2
(en)
*
|
2002-02-06 |
2010-10-26 |
Expression Technologies Inc. |
De novo synthesized plasmid, methods of making and use thereof
|
KR101011410B1
(ko)
*
|
2002-02-13 |
2011-01-28 |
위스콘신 얼럼나이 리서어치 화운데이션 |
인플루엔자 바이러스 벡터의 패키징을 위한 신호
|
KR101113432B1
(ko)
*
|
2002-02-13 |
2012-02-29 |
위스콘신 얼럼나이 리서어치 화운데이션 |
인플루엔자 바이러스 벡터의 패키징을 위한 신호
|
JP2005518209A
(ja)
*
|
2002-02-21 |
2005-06-23 |
マウント シナイ スクール オブ メディシン |
組換えマイナス鎖ウイルスrna発現系およびワクチン
|
EP1576090A4
(de)
|
2002-02-21 |
2008-07-16 |
Medimmune Vaccines Inc |
Metapneumovirusstämme und ihre verwendung in impfstofformulierungen und als vektor zur expression antigener sequenzen
|
US7465456B2
(en)
|
2002-04-26 |
2008-12-16 |
Medimmune, Llc |
Multi plasmid system for the production of influenza virus
|
KR101229202B1
(ko)
|
2002-04-26 |
2013-02-01 |
메디뮨 엘엘씨 |
인플루엔자 바이러스의 생산을 위한 다중 플라스미드 시스템
|
NZ537579A
(en)
|
2002-06-10 |
2006-10-27 |
Vaccinex Inc |
C35 peptide epitopes and their analogs
|
CA2494485A1
(en)
*
|
2002-07-25 |
2004-02-05 |
Medimmune, Inc. |
Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies
|
AU2003295339B2
(en)
*
|
2002-09-27 |
2009-03-26 |
Medimmune, Llc |
Functional mutations in respiratory syncytial virus
|
US20070224124A1
(en)
*
|
2002-09-30 |
2007-09-27 |
University Of South Florida |
Novel SH2containing inositol 5'-phosphatase isoform that partners with the Grb2 adapter protein
|
PT2279746E
(pt)
|
2002-11-15 |
2013-12-09 |
Novartis Vaccines & Diagnostic |
Proteínas de superfície de neisseria meningitidis
|
EP2368578A1
(de)
|
2003-01-09 |
2011-09-28 |
Macrogenics, Inc. |
Identifizierung und Herstellung von Antikörpern mit abweichenden FC-Regionen und Anwendungsverfahren dafür
|
GB0308198D0
(en)
|
2003-04-09 |
2003-05-14 |
Chiron Srl |
ADP-ribosylating bacterial toxin
|
AU2004273776B2
(en)
*
|
2003-04-25 |
2010-07-08 |
Medimmune, Llc |
Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
|
US7704720B2
(en)
*
|
2003-04-25 |
2010-04-27 |
Medimmune, Llc |
Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
|
AU2004249133B2
(en)
*
|
2003-05-28 |
2009-05-28 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines and gene therapy
|
EP2581093B1
(de)
|
2003-06-16 |
2015-03-18 |
MedImmune, LLC |
Influenza-Hämagglutinin- und Neuraminidase-Varianten
|
CA2530956A1
(en)
*
|
2003-07-03 |
2005-03-03 |
Board Of Trustees Operating Michigan State University |
Expression of a recombinant transgene
|
WO2005012487A2
(en)
*
|
2003-08-01 |
2005-02-10 |
Invitrogen Corporation |
Compositions and methods for preparing short rna molecules and other nucleic acids
|
US7807646B1
(en)
|
2003-11-20 |
2010-10-05 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
US7763592B1
(en)
*
|
2003-11-20 |
2010-07-27 |
University Of South Florida |
SHIP-deficiency to increase megakaryocyte progenitor production
|
EP1697521B1
(de)
*
|
2003-12-23 |
2010-06-02 |
MedImmune, LLC |
Multiplasmid-system zur erzeugung des grippevirus
|
EP1722815A1
(de)
|
2004-03-09 |
2006-11-22 |
Chiron Corporation |
Influenza-virus-vakzine
|
CN104292321A
(zh)
|
2004-03-29 |
2015-01-21 |
株式会社嘉尔药物 |
新的半乳凝素9 突变体蛋白质及其用途
|
ES2525672T3
(es)
|
2004-05-25 |
2014-12-29 |
Medimmune, Llc |
Variantes de la hemaglutinina y la neuraminidasa de influenza
|
CA2610632C
(en)
|
2004-06-01 |
2022-10-04 |
Mount Sinai School Of Medicine Of New York University |
Genetically engineered swine influenza virus and uses thereof
|
AU2005303817B8
(en)
*
|
2004-11-11 |
2010-09-30 |
Abbott Biologicals B.V. |
Defective influenza virus particles
|
JP2008520248A
(ja)
|
2004-11-19 |
2008-06-19 |
ウィスコンシン・アラムナイ・リサーチ・ファウンデイション |
タンデム転写ユニットを有する組換えインフルエンザベクター
|
RU2435855C2
(ru)
*
|
2004-12-24 |
2011-12-10 |
Солвей Байолоджикалз Б.В. |
Способ продуцирования репликативной частицы вируса гриппа, композиция клеток (варианты), композиция клеточной культуры и ее применение
|
AU2011204881B2
(en)
*
|
2004-12-24 |
2012-04-19 |
Abbott Biologicals B.V. |
Rescue of influenza virus
|
WO2006088481A2
(en)
*
|
2005-02-15 |
2006-08-24 |
Mount Sinai School Of Medicine Of New York University |
Genetically engineered equine influenza virus and uses thereof
|
EP1856271A4
(de)
|
2005-03-08 |
2009-11-18 |
Medimmune Vaccines Inc |
Influenza-hämagglutinin- und neuraminidase-varianten
|
EP1869225A4
(de)
*
|
2005-03-10 |
2010-02-24 |
Medimmune Vaccines Inc |
Metapneumovirenstämme und ihre verwendung in impfstoffformulierungen und als vektoren für die expression antigener sequenzen und verfahren zur ausbreitung des virus
|
JP4976376B2
(ja)
*
|
2005-04-08 |
2012-07-18 |
メディミューン,エルエルシー |
哺乳動物メタニューモウイルスに対する抗体
|
WO2008157379A2
(en)
|
2007-06-21 |
2008-12-24 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
CA2605024C
(en)
|
2005-04-15 |
2018-05-22 |
Macrogenics, Inc. |
Covalent diabodies and uses thereof
|
SI2573114T1
(sl)
|
2005-08-10 |
2016-08-31 |
Macrogenics, Inc. |
Identifikacija in inženiring protiteles z variantnimi fc regijami in postopki za njih uporabo
|
US9119810B2
(en)
*
|
2005-11-18 |
2015-09-01 |
Rutgers, The State University Of New Jersey |
Compositions and vaccines against influenza A and influenza B infections
|
GEP20135924B
(en)
|
2005-12-02 |
2013-10-10 |
The Mount Sinai School Of Medicine Of New York Univ |
Chimeric viruses presenting non-native surface proteins and usage thereof
|
CA2647985C
(en)
|
2006-03-31 |
2014-12-30 |
Warf-Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses for vaccines
|
RU2457250C2
(ru)
|
2006-04-19 |
2012-07-27 |
Медиммуне, Ллк |
Способы и композиции для экспрессии антисмысловой вирусной рнк в клетках собаки
|
ATE522541T1
(de)
|
2006-06-09 |
2011-09-15 |
Novartis Ag |
Bakterielle adhäsine konformere
|
US7507411B2
(en)
*
|
2006-06-23 |
2009-03-24 |
University Of Saskatchewan |
Attenuated influenza NS1 variants
|
EP2049662A4
(de)
*
|
2006-07-21 |
2009-12-30 |
Medimmune Llc |
Verfahren und zusammensetzungen zur erhöhung des replikationsvermögens eines influenza-virus
|
JP2010500034A
(ja)
|
2006-08-09 |
2010-01-07 |
メッドイミューン バクシーンズ,インコーポレイティド |
インフルエンザ赤血球凝集素変異体およびノイラミニダーゼ変異体
|
KR20140075022A
(ko)
|
2006-09-15 |
2014-06-18 |
메디뮨 엘엘씨 |
높은 역가로 바이러스 증식을 지원하는 mdck 세포주 및 이를 이용한 생물반응기 공정
|
US20090098529A1
(en)
|
2006-10-16 |
2009-04-16 |
Nanhai Chen |
Methods for attenuating virus strains for diagnostic and therapeutic uses
|
WO2008147496A2
(en)
*
|
2007-05-04 |
2008-12-04 |
Warf - Wisconsin Alumni Research Foundation |
Neuraminidase-deficient live influenza vaccines
|
ES2523587T3
(es)
|
2007-06-18 |
2014-11-27 |
Medimmune, Llc |
Virus influenza B que tienen alteraciones en el polipéptido hemaglutinina
|
US9474798B2
(en)
|
2007-06-18 |
2016-10-25 |
Wisconsin Alumni Research Foundation |
Influenza M2 protein mutant viruses as live influenza attenuated vaccines
|
US20090186050A1
(en)
*
|
2007-11-16 |
2009-07-23 |
Fouchier Ron A M |
Live attenuated metapneumovirus strains and their use in vaccine formulations and chimeric metapneumovirus strains
|
CA2730408A1
(en)
*
|
2008-07-11 |
2010-01-14 |
Chin-Fen Yang |
Influenza hemagglutinin and neuraminidase variants
|
KR20110074563A
(ko)
|
2008-09-24 |
2011-06-30 |
메디뮨 엘엘씨 |
바이러스의 정제 방법
|
SI2786762T1
(sl)
|
2008-12-19 |
2019-07-31 |
Macrogenics, Inc. |
Kovalentna diatelesa in njihove uporabe
|
WO2010091262A1
(en)
|
2009-02-05 |
2010-08-12 |
Mount Sinai School Of Medicine Of New York University |
Chimeric newcastle disease viruses and uses thereof
|
BRPI1008549A2
(pt)
*
|
2009-02-12 |
2016-03-15 |
Medimmune Llc |
variantes de neuraminidase e hemaglutinina de influenza
|
CA2787099A1
(en)
|
2009-03-30 |
2010-10-14 |
Anice C. Lowen |
Influenza virus hemagglutinin polypeptides containing stem domains, vaccines and uses thereof
|
US9217157B2
(en)
|
2009-07-27 |
2015-12-22 |
Icahn School Of Medicine At Mount Sinai |
Recombinant influenza viruses and uses thereof
|
US8828406B2
(en)
|
2009-07-30 |
2014-09-09 |
Icahn School Of Medicine At Mount Sinai |
Influenza viruses and uses thereof
|
US9096877B2
(en)
|
2009-10-07 |
2015-08-04 |
Macrogenics, Inc. |
Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use
|
EP2493912B1
(de)
|
2009-10-26 |
2020-07-29 |
Wisconsin Alumni Research Foundation |
Rekombinante influenzaviren mit hohem titer und erhöhter replikation in vero-zellen
|
US10130697B2
(en)
|
2010-03-23 |
2018-11-20 |
Wisconsin Alumni Research Foundation (Warf) |
Vaccines comprising mutant attenuated influenza viruses
|
AU2011235220B2
(en)
|
2010-03-30 |
2016-03-10 |
Mount Sinai School Of Medicine |
Influenza virus vaccines and uses thereof
|
CA2836977A1
(en)
*
|
2010-06-06 |
2011-12-15 |
Benjamin R. Tenoever |
Recombinant rna viruses and uses thereof
|
CA2807127C
(en)
|
2010-08-02 |
2019-02-12 |
Leslie S. Johnson |
Covalent diabodies and uses thereof
|
KR102030531B1
(ko)
|
2011-05-21 |
2019-10-10 |
마크로제닉스, 인크. |
탈면역화된 혈청-결합 도메인 및 혈청 반감기를 연장하기 위한 그것의 용도
|
US20130189303A1
(en)
|
2011-08-02 |
2013-07-25 |
Yan Zhou |
Recombinant swine influenza virus and uses thereof
|
US9101653B2
(en)
|
2011-08-26 |
2015-08-11 |
Wisconsin Alumni Research Foundation |
Influenza viruses with mutant PB2 gene segment as live attenuated vaccines
|
MX2014003308A
(es)
|
2011-09-20 |
2015-03-09 |
Sinai School Medicine |
Vacunas para el virus de la influenza y usos de las mismas.
|
WO2013130132A1
(en)
|
2011-10-07 |
2013-09-06 |
Medimmune, Llc |
Influenza hemagglutinin variants
|
CN108641002A
(zh)
|
2012-12-18 |
2018-10-12 |
西奈山伊坎医学院 |
流感病毒疫苗及其用途
|
WO2014159960A1
(en)
|
2013-03-14 |
2014-10-02 |
Icahn School Of Medicine At Mount Sinai |
Antibodies against influenza virus hemagglutinin and uses thereof
|
NZ711946A
(en)
|
2013-03-14 |
2020-05-29 |
Icahn School Med Mount Sinai |
Newcastle disease viruses and uses thereof
|
CA2953917C
(en)
|
2013-07-01 |
2021-10-19 |
The Research Foundation For The State University Of New York |
Ship inhibition to combat obesity
|
WO2015009743A1
(en)
|
2013-07-15 |
2015-01-22 |
Wisconsin Alumni Research Foundation |
High titer recombinant influenza viruses with enhanced replication in mdck or vero cells or eggs
|
EP3441084A1
(de)
|
2014-02-27 |
2019-02-13 |
Viralytics Limited |
Onkolytisches virus und immunstimulator zur kombinationsbehandlung von krebs
|
AU2015277194B2
(en)
|
2014-06-17 |
2020-10-22 |
The Research Foundation For The State University Of New York |
Ship inhibition to induce activation of natural killer cells
|
US10053671B2
(en)
|
2014-06-20 |
2018-08-21 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to additional genes in influenza viruses
|
WO2016074644A1
(en)
*
|
2014-11-13 |
2016-05-19 |
Versitech Limited |
Live attenuated vaccines for influenza viruses
|
US10736956B2
(en)
|
2015-01-23 |
2020-08-11 |
Icahn School Of Medicine At Mount Sinai |
Influenza virus vaccination regimens
|
MX2017010908A
(es)
|
2015-02-26 |
2017-12-07 |
Boehringer Ingelheim Vetmedica Gmbh |
Vacuna bivalente contra el virus de gripe porcina.
|
US10633422B2
(en)
|
2015-06-01 |
2020-04-28 |
Wisconsin Alumni Research Foundation (Warf) |
Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA
|
WO2017007839A1
(en)
|
2015-07-06 |
2017-01-12 |
Wisconsin Alumni Research Foundation (Warf) |
Improved influenza virus replication for vaccine development
|
WO2017031401A2
(en)
|
2015-08-20 |
2017-02-23 |
University Of Rochester |
Ns1 truncated virus for the development of canine influenza vaccines
|
US10548966B2
(en)
|
2015-08-20 |
2020-02-04 |
University Of Rochester |
Single-cycle virus for the development of canine influenza vaccines
|
WO2017031404A1
(en)
|
2015-08-20 |
2017-02-23 |
University Of Rochester |
Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus
|
EP3341018A1
(de)
|
2015-08-28 |
2018-07-04 |
Wisconsin Alumni Research Foundation |
Erzeugung von infektiösen influenza-viren aus virusähnlichen partikeln
|
JP2019510481A
(ja)
|
2016-02-19 |
2019-04-18 |
ウィスコンシン アルムニ リサーチ ファンデイション |
ワクチン開発のための改善されたb型インフルエンザウイルス複製
|
CA3026256A1
(en)
|
2016-06-03 |
2017-12-07 |
University Of Rochester |
Equine influenza virus live-attenuated vaccines
|
JP7237344B2
(ja)
|
2016-06-15 |
2023-03-13 |
アイカーン スクール オブ メディシン アット マウント サイナイ |
インフルエンザウイルス血球凝集素タンパク質及びその使用
|
CA3058652A1
(en)
|
2017-04-07 |
2018-10-11 |
Icahn School Of Medicine At Mount Sinai |
Anti-influenza b virus neuraminidase antibodies and uses thereof
|
JOP20190256A1
(ar)
|
2017-05-12 |
2019-10-28 |
Icahn School Med Mount Sinai |
فيروسات داء نيوكاسل واستخداماتها
|
CA3087239A1
(en)
|
2018-02-27 |
2019-09-06 |
University Of Rochester |
Multivalent live-attenuated influenza vaccine for prevention and control of equine influenza virus (eiv) in horses
|
US11166996B2
(en)
|
2018-12-12 |
2021-11-09 |
Flagship Pioneering Innovations V, Inc. |
Anellovirus compositions and methods of use
|
US11241492B2
(en)
|
2019-01-23 |
2022-02-08 |
Wisconsin Alumni Research Foundation (Warf) |
Mutations that confer genetic stability to genes in influenza viruses
|
WO2020163804A1
(en)
|
2019-02-08 |
2020-08-13 |
Wisconsin Alumni Research Foundation (Warf) |
Humanized cell line
|
MX2021010343A
(es)
|
2019-02-27 |
2022-01-18 |
Univ Rochester |
Vacuna para la influenza multivalente con virus vivo atenuado para la prevencion y el control del virus de la influenza equina (eiv) en caballos.
|
CN114929269A
(zh)
|
2019-05-01 |
2022-08-19 |
威斯康星校友研究基金会(Warf) |
用于疫苗开发的改进的流感病毒复制
|
US11807872B2
(en)
|
2019-08-27 |
2023-11-07 |
Wisconsin Alumni Research Foundation (Warf) |
Recombinant influenza viruses with stabilized HA for replication in eggs
|